학술논문

First-in-human phase I study of the oral inhibitor of indoleamine 2,3-dioxygenase-1 epacadostat (INCB024360) in patients with advanced solid malignancies
Document Type
Article
Source
In: Clinical Cancer Research. (Clinical Cancer Research, 1 July 2017, 23(13):3269-3276)
Subject
Language
English
ISSN
15573265
10780432